Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.
about
miRNA-133 augments coelomocyte phagocytosis in bacteria-challenged Apostichopus japonicus via targeting the TLR component of IRAK-1 in vitro and in vivo.Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms.Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.Immunological Markers for PML Prediction in MS Patients Treated with NatalizumabNatalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent.Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis.The use of immune modulating drugs for the treatment of multiple sclerosis.The role for microRNAs in drug toxicity and in safety assessment.JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients.Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children.Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective.Physical rehabilitation modulates microRNAs involved in multiple sclerosis: a case report.Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease.Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis.miR-145 and miR20a-5p Potentially Mediate Pleiotropic Effects of Interferon-Beta Through Mitogen-Activated Protein Kinase Signaling Pathway in Multiple Sclerosis Patients.Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation.
P2860
Q28646005-AD50B497-B8A2-4B8D-80B1-1A84F303E7FEQ31134332-075A1218-D4CE-42D9-9A30-D751B4BAB07BQ34803324-0DFCE56E-6007-4145-A89D-4EA3B8ECF5C4Q34818048-FCB27899-BDBF-487B-9E18-2B4A984E5F21Q36054501-C856A546-4E05-4451-A158-B0B843B406D1Q36527783-66BB5511-BC99-4D4D-A009-8D6D781FD24DQ36767522-E4586D39-055C-4138-A228-876D8AA9EE14Q37307396-49D840FB-85D1-4CEB-AFDA-2A02253F5A27Q37577290-AEAF4FB7-2D1E-4D72-91C9-8539BDBC67CBQ38367620-BE2FB29F-777C-4C99-96CD-D16CEA049AD4Q38612977-7939FFAD-8043-4CEE-B4BC-5BD7485CBA01Q38619288-AB1E6AAA-2AEB-4EEA-97FB-35496AB42619Q39046213-F9616FCB-0970-42BA-869B-A553E8221479Q47130533-D05F936C-4115-4C61-A6B1-BA03AEA5460CQ47395782-A701D509-C1E0-4108-98F0-7574C09E4D5EQ48343851-B68C377F-DCAE-444D-BC30-5293A9E55DBAQ50922749-BB60AE51-AB57-4E54-BC5C-F0D0305D996AQ51381933-FBA0D512-7F07-49BC-B7E8-FF0D7015CA52Q55265126-A043B539-2305-40FA-B8D2-AE4E2CD6B731
P2860
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Blood miRNA expression pattern ...... n multiple sclerosis patients.
@en
Blood miRNA expression pattern ...... n multiple sclerosis patients.
@nl
type
label
Blood miRNA expression pattern ...... n multiple sclerosis patients.
@en
Blood miRNA expression pattern ...... n multiple sclerosis patients.
@nl
prefLabel
Blood miRNA expression pattern ...... n multiple sclerosis patients.
@en
Blood miRNA expression pattern ...... n multiple sclerosis patients.
@nl
P2093
P2860
P921
P356
P1476
Blood miRNA expression pattern ...... in multiple sclerosis patients
@en
P2093
I Lopetegi
J Olascoaga
L Sepúlveda
M Muñoz-Culla
M Sáenz-Cuesta
S E Baranzini
T Castillo-Triviño
P2860
P304
P356
10.1177/1352458514534513
P577
2014-05-22T00:00:00Z